title: 5-Lipoxygenase facilitates healing after myocardial infarction.
abstract: Early healing after myocardial infarction (MI) is characterized by a strong inflammatory reaction. Most leukotrienes are pro-inflammatory and are therefore potential mediators of healing and remodeling after myocardial ischemia. The enzyme 5-lipoxygenase (5-LOX) has a key role in the transformation of arachidonic acid in leukotrienes. Thus, we tested the effect of 5-LOX on healing after MI. After chronic coronary artery ligation, early mortality was significantly increased in 5-LOX(-/-) when compared to matching wildtype (WT) mice due to left ventricular rupture. This effect could be reproduced in mice treated with the 5-LOX inhibitor Zileuton. A perfusion mismatch due to the vasoactive potential of leukotrienes is not responsible for left ventricular rupture since local blood flow assessed by magnetic resonance perfusion measurements was not different. However, after MI, there was an accentuation of the inflammatory reaction with an increase of pro-inflammatory macrophages. Yet, mortality was not changed in chimeric mice (WT vs. 5-LOX(-/-) bone marrow in 5-LOX(-/-) animals), indicating that an altered function of 5-LOX(-/-) inflammatory cells is not responsible for the phenotype. Collagen production and accumulation of fibroblasts were significantly reduced in 5-LOX(-/-) mice in vivo after MI. This might be due to an impaired migration of 5-LOX(-/-) fibroblasts, as shown in vitro to serum. In conclusion, a lack or inhibition of 5-LOX increases mortality after MI because of healing defects. This is not mediated by a change in local blood flow, but through an altered inflammation and/or fibroblast function.
authors.affiliation: Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
authors.forename: Nadja
authors.initials: N
authors.lastname: Blömer
authors.forename: Christina
authors.initials: C
authors.lastname: Pachel
authors.forename: Ulrich
authors.initials: U
authors.lastname: Hofmann
authors.forename: Peter
authors.initials: P
authors.lastname: Nordbeck
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Bauer
authors.forename: Denise
authors.initials: D
authors.lastname: Mathes
authors.forename: Anna
authors.initials: A
authors.lastname: Frey
authors.forename: Barbara
authors.initials: B
authors.lastname: Bayer
authors.forename: Benjamin
authors.initials: B
authors.lastname: Vogel
authors.forename: Georg
authors.initials: G
authors.lastname: Ertl
authors.forename: Johann
authors.initials: J
authors.lastname: Bauersachs
authors.forename: Stefan
authors.initials: S
authors.lastname: Frantz
mesh_terms: D000818:Animals; D001094:Arachidonate 5-Lipoxygenase / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D002465:Cell Movement / Q000502:physiology; D003094:Collagen / Q000378:metabolism; D004195:Disease Models, Animal; D005347:Fibroblasts / Q000473:pathology; D007249:Inflammation / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009203:Myocardial Infarction / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D020257:Ventricular Remodeling / Q000502:physiology*; D014945:Wound Healing / Q000502:physiology*
chemical_list: D003094:Collagen; D001094:Arachidonate 5-Lipoxygenase